Skip to main content

SCR 19 — Missouri

Expresses support for TrumpRx and the GENEROUS Model

Introduced 2026 session Senate

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

SCR 19 - This concurrent resolution urges the U.S. Department of Health and Human Services to prevent discriminatory insurance practices and require insurance plans and pharmacy benefit managers to apply all patient-paid prescription drug expenditures, including those obtained through the new TrumpRx platform, toward patients' cost-sharing requirements. Additionally, this concurrent resolution urges the Department of Social Services to assess the new GENEROUS Model for MO HealthNet participation.
SARAH HASKINS

Official abstract, as published by the legislature.

  • SCR 19 is a concurrent resolution in the Missouri Senate, 2026 session, introduced February 5, 2026.
  • Sponsored by Nick Schroer.
  • Current status: introduced.
  • Most recent action (February 9, 2026): Referred S Rules, Joint Rules, Resolutions and Ethics Committee.
  • Subjects: Drugs and Controlled Substances, Health Care, Insurance - Health, Medicaid/MO Healthnet, Pharmacy, Public Assistance.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Nick Schroer

History

  1. Introduced, completed
  2. Passed Senate, in progress
  3. Passed House, not reached yet
  1. Senate S Offered Milestone
  2. Senate Referred S Rules, Joint Rules, Resolutions and Ethics Committee Latest

Source: Open States. Last checked November 1, 2026. How we keep this accurate ›